The crisis in drug pricing has reached global proportions. According to a recent article in The Economist, “THESE DAYS it is hard to find a government that is not struggling with the high price of medicines. …[T]he unaffordability of medicines…[is at] the top of the global health agenda”.
The pricing crisis has emerged because of pharma’s success in treating debilitating diseases. After decades of research, despite staggering odds, the industry is making drugs that can deal with conditions like cystic fibrosis, cancer and hepatitis. However, high prices can limit access for patients.
